Clinical Trial Update: 24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients [Phase 4]

View source ↗

Summary

This entry describes a Phase 4 trial comparing Rocklatan to latanoprost in open-angle glaucoma and ocular hypertension, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)
• ROCKLATAN (Netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%)

Snippet

Sponsor: Mayo Clinic | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 4 | Status: RECRUITING